Evidence map›Paper›PMID 29987827›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2018

The Mouse Aortocaval Fistula Model with Intraluminal Drug Delivery.

Toshihiko Isaji, Alan Dardik

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
6.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Toshihiko IsajiVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
Alan DardikVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA. alan.dardik@yale.edu.
Yale University · US

Funding

Enhancing venous adaptation to the arterial environmentR01HL128406 · NHLBI · YALE UNIVERSITY · PI DARDIK, ALAN · 2016 to 2019
$1.9M
BLRD VA I01 BX002336NHLBI NIH HHS R01 HL128406
6 · The paper itself

Abstract

The arteriovenous fistula (AVF) is the most common type of vascular access currently used for hemodialysis, but long-term outcomes remain poor in many patients; understanding the basic mechanisms of venous remodeling within the fistula environment is critical to improve our understanding of AVF maturation. In this chapter, we describe a method to create a murine aortocaval fistula that allows intraluminal drug delivery. This model reliably recapitulates human AVF maturation and therefore is a good consideration to study venous remodeling.

Indexed as

Drug Delivery SystemsAnimalsAortaArteriovenous FistulaDisease Models, AnimalMiceMice, Inbred C57BLRenal DialysisVascular RemodelingVenae CavaeAnimal modelAortocaval fistulaArteriovenous fistulaFistula maturationHemodialysis accessIntraluminal drug delivery

Identifiers

PMID29987827
PMCPMC13004824
OpenAlexW2850970727

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.